Logo image of ADAP

ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) Stock Analyst Ratings

NASDAQ:ADAP - Nasdaq - US00653A1079 - ADR - Currency: USD

0.2423  -0.01 (-3.08%)

After market: 0.2584 +0.02 (+6.64%)

Buy % Consensus

76

ChartMill assigns a Buy % Consensus number of 76% to ADAP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 1.61. This target is 563.53% above the current price.
ADAP was analyzed by 14 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about ADAP.
In the previous month the buy percentage consensus was at a similar level.
ADAP was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
ADAP Historical Analyst RatingsADAP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -102 -92 -82 -72 -62 -52 -42 -32 -22 -12 -2 5 10 15

Price Target & Forecast

Price Low Median Mean High 0.240.461.531.613.15 - 91.75% 531.45% 563.53% 1,200.04%
ADAP Current Analyst RatingADAP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2025-05-14 Barclays Maintains Underweight -> Underweight
2025-05-14 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2025-04-01 HC Wainwright & Co. Maintains Buy -> Buy
2025-03-26 Guggenheim Maintains Buy -> Buy
2025-03-21 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2025-03-21 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2024-11-27 Mizuho Maintains Outperform -> Outperform
2024-11-19 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-15 Guggenheim Maintains Buy -> Buy
2024-11-14 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-05 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-30 HC Wainwright & Co. Initiate Buy
2024-05-30 ScotiaBank Initiate Sector Outperform
2024-05-17 Mizuho Maintains Buy -> Buy
2023-08-10 EF Hutton Reiterate Buy -> Buy
2023-08-10 Barclays Maintains Underweight -> Underweight
2023-06-05 EF Hutton Reiterate Buy -> Buy
2023-06-02 EF Hutton Reiterate Buy
2023-05-26 EF Hutton Reiterate Buy
2023-04-17 EF Hutton Reiterate Buy
2023-04-11 EF Hutton Reiterate Buy
2023-03-06 EF Hutton Reiterate Buy
2023-01-05 EF Hutton Initiate Buy
2023-01-03 Guggenheim Upgrade Neutral -> Buy
2022-11-14 Wells Fargo Maintains Equal-Weight
2022-11-09 Mizuho Upgrade Neutral -> Buy
2022-10-04 Wells Fargo Maintains Equal-Weight
2022-05-09 SVB Leerink Maintains Market Perform
2021-09-22 Wells Fargo Maintains Equal-Weight